CIK 0001722482 · Large accelerated filer
Avantor, Inc.
Sign in to watch- Ticker
- AVTR
- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822758923
- Phone
- (610) 386-1700
- Business address
- RADNOR CORPORATE CENTER, BUILDING ONE, SUITE 200, 100 MATSONFORD ROAD, RADNOR, PA, 19087
- Former names
- Vail Holdco Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-22 | Eck Steven W SVP & Chief Accounting Officer | Shares withheld for taxes | −449 | $28.69 | $13K | 19,982 |
| 2021-02-22 | Vanderhaegen Frederic EVP, Europe | Shares withheld for taxes | −398 | $28.69 | $11K | 237,388 |
| 2021-02-22 | Stubblefield Michael President and CEO | Shares withheld for taxes | −10,141 | $28.69 | $291K | 1,437,122 |
| 2021-02-22 | Bramwell James EVP, Strategic Partners | Shares withheld for taxes | −1,216 | $28.69 | $35K | 115,214 |
| 2021-02-22 | Ohri Devashish EVP, IMEA | Shares withheld for taxes | −1,210 | $28.69 | $35K | 150,461 |
| 2021-02-22 | Szlosek Thomas A EVP & CFO | Shares withheld for taxes | −2,980 | $28.69 | $85K | 256,374 |
| 2021-02-05 | Wondrasch Michael EVP & CIO | Sale | −9,468 | $29.77 | $282K | 141,543 |
| 2021-02-05 | Wondrasch Michael EVP & CIO | Option exercise | +40,000 | $23.20 | $928K | 181,543 |
| 2021-02-05 | Wondrasch Michael EVP & CIO | Sale | −40,000 | $29.77 | $1.2M | 141,543 |
| 2021-02-05 | Wondrasch Michael EVP & CIO | Option exercise · Stock Options (Right to Buy) | −40,000 | 230,415 | ||
| 2021-01-13 | Murray Mark Christopher EVP, Biomaterials & AT | Shares withheld for taxes | −918 | $29.20 | $27K | 11,458 |
| 2021-01-11 | Bramwell James EVP, Strategic Partners | Sale | −2,505 | $30.00 | $75K | 116,430 |
| 2021-01-11 | Brophy Gerard EVP, Biopharma Production | Option exercise | +216,332 | $23.20 | $5.0M | 394,847 |
| 2021-01-11 | Brophy Gerard EVP, Biopharma Production | Sale | −216,332 | $30.08 | $6.5M | 178,515 |
| 2021-01-11 | Brophy Gerard EVP, Biopharma Production | Option exercise | +162,248 | $23.20 | $3.8M | 340,763 |
| 2021-01-11 | Brophy Gerard EVP, Biopharma Production | Sale | −162,248 | $30.04 | $4.9M | 178,515 |
| 2021-01-11 | Brophy Gerard EVP, Biopharma Production | Option exercise · Stock Options (Right to Buy) | −162,248 | 162,250 | ||
| 2021-01-06 | Brophy Gerard EVP, Biopharma Production | Sale | −11,509 | $27.24 | $314K | 178,515 |
| 2021-01-04 | Brophy Gerard EVP, Biopharma Production | Option exercise | +59,418 | $18.45 | $1.1M | 249,442 |
| 2021-01-04 | Brophy Gerard EVP, Biopharma Production | Sale | −59,418 | $27.84 | $1.7M | 190,024 |
Page 28 of 44 · 874 trades